Hyundai Motor India today handed over COVID-19 Advanced Diagnostic Testing Kits to Indian Council of Medical Research (ICMR). The globally proven Diagnostic Kits worth Rs 4 Crore have been imported from South Korea and offer high levels of accuracy, catering to the testing requirements of over 25000 individuals. These Diagnostic Kits are also being exported to USA, Europe and other countries.
Commenting on the handover, Mr. SS Kim, MD & CEO, Hyundai Motor India Ltd. said, “As a socially responsible and caring brand, Hyundai is committed to the fight against COVID-19. To provide further assistance to the Government’s efforts, we have handed over Globally Proven – COVID-19 Advanced Diagnostic Testing Kits imported from South Korea. These highly accurate diagnostic kits can help the Government scale up the testing efforts in affected regions and arrest the spread of the COVID-19 pandemic in India.”
As part of Hyundai’s road map of giving back to the society, series of initiatives have been developed to assist the Government in the battle against COVID-19. The range of initiatives include:
Donation of Rs 5 Crore to Tamil Nadu Chief Minster Relief Fund
Augment the supply of ventilators and other respiratory aids such as the in-house developed Ambu Bag Actuator
Distribution of PPEs, masks and other safety kits
Distribution of dry rations to adversely impacted sections of society
Hyundai has also announced initiatives to support customers in these challenging times. Customers who were unable to avail vehicle’s Warranty/Extended Warranty/Free Service due to Health Emergency or Dealership shutdown in affected cities, HMI will offer extended support of 2 months. Customers (Doctors/Police/Bankers etc) who are in essential services are already being given Road Side Assistance by Allianz Partner/Dealers, in case of any emergency.
Hyundai Motor also entered into a partnership with Air Liquide Medical Systems Pvt. Ltd. (ALMS) a Manufacturer of ICU Ventilators, to augment the production and supply of Ventilators in Tamil Nadu and other states. With this partnership HMI and ALMS aim to achieve a target of 1000 ventilators in the Phase 1 of production, and to scale up subsequently.
Ventilators are medical devices used by healthcare professionals that take over the work of breathing from a patient who is unable to breathe on their own by delivering air with high concentration of oxygen to their lungs. For patients severely affected by COVID-19, ventilators are critical to ensure continuous oxygen is supplied to overcome respiratory insufficiency.
